Computed tomography dose index and dose length product for cone-beam CT: Monte Carlo simulations.

Loading...

Date

2011-01-19

Journal Title

Journal ISSN

Volume Title

Repository Usage Stats

1630
views
82
downloads

Citation Stats

Attention Stats

Abstract

Dosimetry in kilovoltage cone beam computed tomography (CBCT) is a challenge due to the limitation of physical measurements. To address this, we used a Monte Carlo (MC) method to estimate the CT dose index (CTDI) and the dose length product (DLP) for a commercial CBCT system. As Dixon and Boone showed that CTDI concept can be applicable to both CBCT and conventional CT, we evaluated weighted CT dose index (CTDI(w)) and DLP for a commercial CBCT system. Two extended CT phantoms were created in our BEAMnrc/EGSnrc MC system. Before the simulations, the beam collimation of a Varian On-Board Imager (OBI) system was measured with radiochromic films (model: XR-QA). The MC model of the OBI X-ray tube, validated in a previous study, was used to acquire the phase space files of the full-fan and half-fan cone beams. Then, DOSXYZnrc user code simulated a total of 20 CBCT scans for the nominal beam widths from 1 cm to 10 cm. After the simulations, CBCT dose profiles at center and peripheral locations were extracted and integrated (dose profile integral, DPI) to calculate the CTDI per each beam width. The weighted cone-beam CTDI (CTDI(w,l)) was calculated from DPI values and mean CTDI(w,l) (CTDI(w,l)) and DLP were derived. We also evaluated the differences of CTDI(w) values between MC simulations and point dose measurements using standard CT phantoms. In results, it was found that CTDI(w,600) was 8.74 ± 0.01 cGy for head and CTDI(w,900) was 4.26 ± 0.01 cGy for body scan. The DLP was found to be proportional to the beam collimation. We also found that the point dose measurements with standard CT phantoms can estimate the CTDI within 3% difference compared to the full integrated CTDI from the MC method. This study showed the usability of CTDI as a dose index and DLP as a total dose descriptor in CBCT scans.

Department

Description

Provenance

Subjects

Humans, Tomography, X-Ray Computed, Calibration, Models, Statistical, Monte Carlo Method, Equipment Design, Radiometry, Radiation Dosage, Film Dosimetry, Phantoms, Imaging, Computer Simulation, Cone-Beam Computed Tomography

Citation

Published Version (Please cite this version)

10.1120/jacmp.v12i2.3395

Publication Info

Kim, Sangroh, Haijun Song, Ehsan Samei, Fang-Fang Yin and Terry T Yoshizumi (2011). Computed tomography dose index and dose length product for cone-beam CT: Monte Carlo simulations. Journal of applied clinical medical physics, 12(2). p. 3395. 10.1120/jacmp.v12i2.3395 Retrieved from https://hdl.handle.net/10161/19391.

This is constructed from limited available data and may be imprecise. To cite this article, please review & use the official citation provided by the journal.

Scholars@Duke

Samei

Ehsan Samei

Reed and Martha Rice Distinguished Professor of Radiology

Dr. Ehsan Samei, PhD, DABR, FAAPM, FSPIE, FAIMBE, FIOMP, FACR is a Persian-American medical physicist. He is the Reed and Martha Rice Distinguished Professor of Radiology, and Professor of Medical Physics, Biomedical Engineering, Physics, and Electrical and Computer Engineering at Duke University. He serves as the Chief Imaging Physicist for Duke University Health System, the Director of the Carl E Ravin Advanced Imaging Laboratories and the Center for Virtual Imaging Trials (CVIT), and Co-Director of the Triangle Centers of Excellence in Regulatory Science and Innovation (Triangle CERSI). Certified by the American Board of Radiology, he is recognized as a Distinguished Investigator by the Academy of Radiology Research, awarded Fellow by five professional organizations, and has been the recipient of the Jimmy O. Fenn Lifetime Achievement Award of SEAAPM and the Marie Sklodowska-Curie Award by IOMP. He founded/co-founded the Duke Medical Physics Program, the Duke Imaging Physics Residency Program, the Duke Clinical Imaging Physics Group, the Center for Virtual Imaging Trials, and the Society of Directors of Academic Medical Physics Programs (SDAMPP). He has held senior leadership positions in the AAPM, SPIE, SDAMPP, and RSNA, including election to the presidency of the SEAAPM (2010-2011), SDAMPP (2011), and AAPM (2023). He is ranked 11th among over 56,000 medical physicists worldwide for his lifetime contribution to medical physics.

Dr. Samei’s scientific expertise includes x-ray imaging, theoretical imaging models, simulation methods, and experimental techniques in medical image formation, quantification, and perception.  His research aims to bridge the gap between scientific scholarship and clinical practice, facilitating the meaningful realization of translational research and informing clinical processes with scientific evidence. He has advanced image quality and safety metrics and radiometrics that are clinically relevant and that can be used to design, optimize, and monitor interpretive and quantitative performance of imaging techniques. These have been implemented in advanced imaging performance characterization, procedural optimization, and clinical dose and quality analytics. His most recent research interests have been virtual clinical trials across a broad spectrum of oncologic, pulmonary, cardiac, and vascular diseases, and developing methodological advances that provide smart fusions of principle-informed and AI-based, data-informed approaches to scientific inquiry.

Dr. Samei has mentored over 150 trainees (graduate and postgraduate). He has about 1400 scientific publications, including over 400 refereed journal articles, over 600 conference presentations, and 4 books. Citations to his work is reflected in an h-index of 79 and a Weighted Relative Citation Ratio of 628. His laboratory has been supported continuously for over two decades by 47 extramural grants totaling over $49 million. Those include a Program Project grant from the NIH in 2021 to establish the National Center for Virtual Imaging Trials (CVIT), and a multi-institutional grant in 2023 from the FDA to establish the Triangle Center of Excellence in Regulatory Science and Innovation (Triangle CERSI), both joining a highly selective biomedical research and regulatory science centers nationwide.

Yin

Fang-Fang Yin

Gustavo S. Montana Distinguished Professor Emeritus of Radiation Oncology

Stereotactic radiosurgery, Stereotactic body radiation therapy, treatment planning optimization, knowledge guided radiation therapy, intensity-modulated radiation therapy, image-guided radiation therapy, oncological imaging and informatics


Unless otherwise indicated, scholarly articles published by Duke faculty members are made available here with a CC-BY-NC (Creative Commons Attribution Non-Commercial) license, as enabled by the Duke Open Access Policy. If you wish to use the materials in ways not already permitted under CC-BY-NC, please consult the copyright owner. Other materials are made available here through the author’s grant of a non-exclusive license to make their work openly accessible.